American Journal of Clinical Pathology · 2014 · 56 citations · 22 references
MedicineOncologyPathologyNeoplasiaThoracic OncologyTumor PathologyImmunohistochemistryLung CancerMalignant NeoplasmsNeuroendocrine TumorsTumor ClassificationTumor MarkersImmunohistochemical StainingLarge Cell Neuroendocrine CarcinomaLung Tumor ClassificationNeuroendocrine Tumor ClassificationNeuroendocrine Tumor GradingNeuroendocrine Tumor HistologyPulmonary Carcinoid TumorsPulmonary Neuroendocrine Tumors
OBJECTIVE: A panel of immunohistochemical (IHC) stains frequently used to subclassify non-small cell lung cancers (NSCLCs) includes napsin A, TTF-1, CK5/6, p40, and p63. The expression profiles of these stains in neuroendocrine tumors have not been systematically evaluated. METHOD: Sixty-eight resected pulmonary neuroendocrine tumors, including 52 typical carcinoids (TCs), eight atypical carcinoids (ACs), seven small cell carcinomas (SCLCs) and one large cell neuroendocrine carcinoma (LCNEC), were stained for napsin A, TTF-1, p63, p40, and CK5/6. Tumors were scored as positive (>1% tumor cells reactive) or negative, and percentage of reactive tumor cells was recorded. RESULTS: Napsin A, p63, p40, and CK5/6 were consistently negative in neuroendocrine tumors. TTF-1 was positive in 17 of 52 TCs, 4 of 8 ACs, 5 of 7 SCLCs, and 0 of 1 LCNECs. CONCLUSION: Pulmonary neuroendocrine tumors have a distinct but nonspecific profile on IHC panel commonly applied to subclassify NSCLCs. They are napsin A-/p40-/p63-/CK5/6-/TTF-1±. Recognizing this profile may have value in separating neuroendocrine tumors from NSCLCs.
22
Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors.
Andrew L. Folpe, A M Gown, Laura W. Lamps et al. · PubMed · 1999 · 255 citations
Bradley M. Turner, Philip T. Cagle, Irma M. Sáinz et al. · Archives of Pathology & Laboratory Medicine · 2012 · 235 citations · Full text